← The Lantern · New Carlisle
health · class ii

Premier Pharmacy Labs Inc recalls Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL…

The stated reason: Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

Premier Pharmacy Labs Inc began a drug recall on August 10, 2017 whose reported distribution included Ohio. FDA

What the record shows

FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 1610 syringes. The recall is listed as terminated. FDA

1 source

Context

This is one of 1 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2883 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: August 10, 2017 FDA
  • Recall number: D-0129-2018 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Premier Pharmacy Labs Inc FDA
  • Product: Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only… FDA
  • Reason for recall: Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data. FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberD-0129-2018
Recalls in this action1
Recalling firmPremier Pharmacy Labs Inc
ProductNeostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Reason for recallStability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typedrug
Quantity1610 syringes
StatusTerminated
Voluntary or mandatedVoluntary: Firm initiated
Initiated20170810
Reported20171227
DistributionMichigan, Maryland, Minnesota, North Carolina, Ohio, Florida
Firm locationWeeki Wachee, FL, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.